Masimo stock: buy or sell?
October 18th, 2019
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide.
Should I buy Masimo stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with Masimo stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Masimo stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we collected 10 ratings published for MASI stock in the last 30 days. The general sentiment of these ratings is bullish for MASI stock, with 8 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-5-7||Piper Jaffray Companies||n/a||Overweight|
|2019-5-17||Piper Jaffray Companies||n/a||n/a|
|2019-4-9||Needham & Company LLC||n/a||Buy|
|2019-3-13||Needham & Company LLC||n/a||Buy|
|2019-2-27||Piper Jaffray Companies||n/a||Overweight|
|2019-2-1||Needham & Company LLC||n/a||Buy|
Masimo stock analysis
Masimo closed on October/18 at $147.87 and remained stable a neutral -0.09%.
Shares of Masimo closed on October 18th at $147.87 and remained constant a neutral -0.09%. On July, MASI hit new all time highs, pushing higher previous ATH of $160.13 recorded on July. New ATHs are usual entry points for many trading setups as there aren't higher resistences.
Masimo shares gained 1.69% this week, ending at $147.87.
MASI marked an uptrend of rising tops and rising bottoms. Since its last top late July at $160.25, price slid and bounced up back from $139.36. Breaking down under $139.36 would cancel the current uptrend and it might test lower supports. Note that $160.25 might act as a resistance line. Not so far away is the last all-time high Masimo marked late July. Early January MASI price bounced up over the SMA of 40 weeks that acted as support stopping new slides. By mid February, SMA10w and SMA20w crossed up triggering a rise of 16.17%.
Masimo stock price history
Masimo stock went public on August 8th, 2007 with a price of $16.471. Since then, MASI stock surged a 797.80%, with an average of 66.50% per year. If you had invested right after MASI's IPO a $1,000 in Masimo stock in 2007, it would worth $7,978.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Masimo stock historical price chart
MASI stock reached all-time highs on July with a price of $160.25.
Masimo stock price target is $156.50How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' MASI stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 8 price predictions for Masimo stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-8-1||UBS Group||Raises Target||$172.00||$180.00||4.7%|
|2019-8-1||Stifel Nicolaus||Raises Target||$165.00||$170.00||3%|
|2019-5-7||UBS Group||Raises Target||$147.00||$160.00||8.8%|
|2019-5-7||Piper Jaffray Companies||Reiterates||$140.00||$148.00||5.7%|
|2019-5-17||Piper Jaffray Companies||Raises Target||$148.00||$160.00||8.1%|
|2019-3-13||Needham & Company LLC||Raises Target||$148.00||$155.00||4.7%|
|2019-2-27||Piper Jaffray Companies||Reiterates||n/a||$140.00||-|
|2019-2-1||Needham & Company LLC||Reiterates||n/a||$139.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareMasimo reported more than good results for 2018-Q4 on February. Masimo rose Earnings per Share (EPS) by 15.30%, beating analysts consensus of $0.72. Masimo posted $0.83.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Masimo annual turnover jumped a pretty good 8.61% to $858.29 million dollars from $790.25 marked in 2017. When comparing 2018 vs 2017, in contrary, profit margin (that is, the net income divided by revenues) rose a 6.76% to 22.55%.
|2013||$547 M||-||$58 M10.7%||-|
|2014||$587 M||7.20%||$73 M12.4%||24.22%|
|2015||$630 M||7.41%||$83 M13.2%||14.87%|
|2016||$695 M||10.24%||$301 M43.3%||260.94%|
|2017||$790 M||13.77%||$125 M15.8%||-58.50%|
|2018||$858 M||8.61%||$194 M22.5%||55.10%|
Quarterly financial resultsMasimo posted $223.13 million in revenues for 2018-Q4, a 5.96% up compared to previous quarter. Reported quarter income marked $46.93 million with a profit margin of 21.03%. Profit margin slipped a -6.09% compared to previous quarter when profit margin was 27.13%. When comparing revenues to same quarter last year, Masimo sales marked a beatiful gain and appreciated a 3.40%.
|2017-Q1||$186 M||-||$45 M24.3%||-|
|2017-Q2||$193 M||3.56%||$47 M24.2%||2.98%|
|2017-Q3||$194 M||0.39%||$39 M20.3%||-15.95%|
|2017-Q4||$216 M||11.41%||$-1 M-0.4%||-102.31%|
|2018-Q1||$213 M||-1.32%||$46 M21.4%||-5,125.33%|
|2018-Q2||$212 M||-0.63%||$44 M20.7%||-3.89%|
|2018-Q3||$211 M||-0.49%||$57 M27.1%||30.27%|
|2018-Q4||$223 M||5.96%||$47 M21.0%||-17.84%|
Masimo ownershipWhen you are planning to buy a stock, it's always worth to review its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Masimo, 8.80% of all outstanding shares are owned by its staff.
Bearish positions for MASI stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Masimo:
|Market cap||$7.9 B||$15.1 B||$2.8 B||$78.2 B||$449.5 M|
|Total shares||53.3 M||292.4 M||28.3 M||8,730.0 M||63.0 M|
|Float shares||49.2 M||297.7 M||27.6 M||8,710.0 M||60.5 M|
|- Institutional holdings (%)||84.4%||92.4%||97.5%||58.6%||98.2%|
|- Insider holdings (%)||8.8%||0.3%||1.8%||0.2%||3.5%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, October 18th, 2019|
|Day range||$146.50 - $148.69|
|Average true range||$3.21|
|50d mov avg||$149.59|
|100d mov avg||$148.65|
|200d mov avg||$139.29|
Masimo performanceTo measure stock performance is always good to benchmark with competitors or related stocks. We selected Cardinal Health, CONMED, General Electric, Owens & Minor, Koninklijke Philips, ResMed, Thermo Fisher Scientific and Universal Forest Products as the bechmarking frame for Masimo stock.
|OMIOwens & Minor||170.45%||111.87%||-51.72%|
|TMOThermo Fisher Sci...||-2.84%||8.47%||24.23%|
|UFPIUniversal Forest ...||15.12%||32.32%||44.78%|